The growing challenge of pediculosis capitis – more commonly called head lice – is getting exacerbated by the prevalent development immunity to conventional treatments. Thankfully, researchers are developing innovative approaches to address these stubborn infestations. Novel therapies include enzyme-based products which uniquely break down lice